- Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection
-
Jeong SH
- KMID: 760731
- Korean J Hepatol.
- 2007 Sep;13(3):301-303.
- doi: 10.3350/kjhep.2007.13.3.301
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary Toxicity by Pegylated Interferon alpha-2a in a Patient with Chronic Hepatitis C
-
Son BK, Sohn JH, Kim TY, Park YK, Jeon YC, Han DS
- KMID: 760711
- Korean J Hepatol.
- 2007 Mar;13(1):103-107.
The combination therapy with pegylated interferon alpha and ribavirin has increasingly prescribed for chronic hepatitis C. Although many side effects of interferon such as flu-like symptoms, gastrointestinal and neuropsychiatric symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Chronic Hepatitis C
-
Chang YJ, Byun KS
- KMID: 772701
- Korean J Gastroenterol.
- 2004 Dec;44(6):301-307.
Chronic infection with HCV represents second most common cause of end-stage liver diseases and hepatocellular carcinoma in Korea. The introduction of new agents and regimens for the treatment of chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C
-
Kim KT, Han SY, Kim JH, Yoon HA, Baek YH, Kim MJ, Lee SW, Jang JS, Lee JH, Roh MH
- KMID: 1073328
- Korean J Hepatol.
- 2008 Mar;14(1):36-45.
- doi: 10.3350/kjhep.2008.14.1.36
BACKGROUND/AIMS: The purpose of this study is to elucidate the efficacy and safety of combined peginterferon and ribavirin therapy in Korean patients with chronic HCV infection. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
